↓ Skip to main content

The efficacy and safety of atogepant for the prophylactic treatment of migraine: evidence from randomized controlled trials

Overview of attention for article published in The Journal of Headache and Pain, January 2022
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (57th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (51st percentile)

Mentioned by

twitter
4 X users

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
24 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The efficacy and safety of atogepant for the prophylactic treatment of migraine: evidence from randomized controlled trials
Published in
The Journal of Headache and Pain, January 2022
DOI 10.1186/s10194-022-01391-2
Pubmed ID
Authors

Xinyu Tao, Zeya Yan, Jiahao Meng, Wei Wang, Qiling Dai, Qiufeng Zhou, Zhifeng Wang, Zhong Wang

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 24 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 24 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 5 21%
Student > Postgraduate 5 21%
Lecturer 2 8%
Other 1 4%
Student > Ph. D. Student 1 4%
Other 3 13%
Unknown 7 29%
Readers by discipline Count As %
Medicine and Dentistry 8 33%
Pharmacology, Toxicology and Pharmaceutical Science 3 13%
Neuroscience 3 13%
Biochemistry, Genetics and Molecular Biology 2 8%
Nursing and Health Professions 1 4%
Other 0 0%
Unknown 7 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 February 2022.
All research outputs
#14,006,272
of 23,849,058 outputs
Outputs from The Journal of Headache and Pain
#893
of 1,417 outputs
Outputs of similar age
#219,231
of 516,993 outputs
Outputs of similar age from The Journal of Headache and Pain
#14
of 29 outputs
Altmetric has tracked 23,849,058 research outputs across all sources so far. This one is in the 40th percentile – i.e., 40% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,417 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 17.6. This one is in the 36th percentile – i.e., 36% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 516,993 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 57% of its contemporaries.
We're also able to compare this research output to 29 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.